tolvaptan has been researched along with Kidney Failure in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 16 (84.21) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Torres, VE; Zhou, JX | 1 |
| Fenton, RA; Gansevoort, RT; Geurts, F; Hoorn, EJ; Kramers, BJ; Meijer, E; Salih, M; Xue, L; Zietse, R | 1 |
| Attia, H; El-Shabrawy, M; Emad Aboulhoda, B; Emam, M; Mishriki, A; Wanas, H | 1 |
| Damman, K; Fujii, H; Fukamizu, S; Goldsmith, SR; Kagiyama, N; Kitai, T; Matsue, Y; Nishioka, T; Noda, M; Onishi, Y; Ono, Y; Satoh, Y; Sugi, K; Suzuki, M; Ter Maaten, JM; Torii, S; van der Meer, P; Voors, AA; Yamaguchi, S; Yoshida, K | 1 |
| Isobe, M; Kamiyama, M; Masumura, M; Nomoto, H; Ohno, M; Oumi, T; Sakakibara, A; Satoh, Y; Sugiyama, T; Suzuki, M; Takahashi, Y; Yabe, K; Yamashita, S | 1 |
| Anzai, H; Fukui, R; Iijima, R; Kobayashi, N; Kogame, N; Niikura, H; Takenaka, H | 1 |
| Hoshiyama, A; Kamata, Y; Masaki, T; Shichiri, M; Takada, T; Toki, T | 1 |
| Ako, J; Ikeda, Y; Inomata, T; Izumi, T; Kida, K; Sato, N; Shibagaki, Y | 1 |
| Ambrosy, AP; Butler, J; Filippatos, G; Gheorghiade, M; Greene, SJ; Konstam, MA; Maggioni, AP; Mentz, RJ; Nodari, S; Subacius, H; Vaduganathan, M | 1 |
| Fujii, H; Matsue, Y; Nagahori, W; Nishioka, T; Noda, M; Okishige, K; Onishi, Y; Ono, Y; Sakurada, H; Satoh, Y; Sugi, K; Suzuki, M; Takahashi, A; Tejima, T; Torii, S; Yamaguchi, S; Yoshida, K | 1 |
| Mager, DE; Mallikaarjun, S; Shoaf, SE; Van Wart, SA | 1 |
| Ambrosy, AP; Butler, J; Chioncel, O; Gheorghiade, M; Givertz, MM; Greene, SJ; Konstam, MA; Maggioni, AP; Mentz, RJ; Senni, M; Subacius, HP; Swedberg, K; Vaduganathan, M; Zannad, F | 1 |
| Hirano, D; Ida, H; Ito, A; Kakegawa, D; Miwa, S; Yamada, A | 1 |
| Amano, A; Kajimoto, K; Kato, TS; Kuwaki, K; Ono, S; Yamamoto, T | 1 |
| Hasegawa, T; Ikeda, U; Izawa, A; Kimura, K; Misawa, T; Momose, T; Morita, T; Motoki, H | 1 |
| Fujii, H; Fukamizu, S; Goldsmith, SR; Kagiyama, N; Kitai, T; Matsue, Y; Nishioka, T; Noda, M; Onishi, Y; Ono, Y; Satoh, Y; Sugi, K; Suzuki, M; Torii, S; Yamaguchi, S; Yoshida, K | 2 |
| Blair, J; Burnett, JC; Gheorghiade, M; Grinfeld, L; Konstam, MA; Krasa, HB; Maggioni, AP; Ouyang, J; Pang, PS; Swedberg, K; Vaduganathan, M; Zannad, F; Zimmer, C | 1 |
| Hashimoto, Y; Iwatsuka, R; Matsue, Y; Matsumura, A; Mizukami, A; Nagahori, W; Ohno, M; Seya, M; Suzuki, M | 1 |
1 review(s) available for tolvaptan and Kidney Failure
| Article | Year |
|---|---|
Autosomal Dominant Polycystic Kidney Disease Therapies on the Horizon.
Topics: Antidiuretic Hormone Receptor Antagonists; Humans; Polycystic Kidney, Autosomal Dominant; Receptors, Vasopressin; Renal Insufficiency; Tolvaptan; United States; Vasopressins | 2023 |
11 trial(s) available for tolvaptan and Kidney Failure
| Article | Year |
|---|---|
Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction.
Topics: Acute Disease; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuresis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glomerular Filtration Rate; Heart Failure; Humans; Hyponatremia; Injections, Intravenous; Male; Renal Insufficiency; Retrospective Studies; Time Factors; Tolvaptan; Treatment Outcome | 2017 |
Mechanisms of Diuresis for Acute Decompensated Heart Failure by Tolvaptan.
Topics: Acute Disease; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Creatinine; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Electric Impedance; Female; Follow-Up Studies; Heart Failure; Humans; Hyponatremia; Male; Middle Aged; Prognosis; Renal Insufficiency; Retrospective Studies; Tolvaptan | 2017 |
Clinical utility of early use of tolvaptan in very elderly patients with acute decompensated heart failure.
Topics: Age Factors; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Female; Health Services for the Aged; Heart Failure; Humans; Japan; Length of Stay; Male; Prospective Studies; Renal Insufficiency; Risk Factors; Survival Analysis; Tolvaptan; Treatment Outcome | 2017 |
Different diuretic properties between tolvaptan and furosemide in congestive heart failure patients with diuretic resistance and renal impairment: a subanalysis of the K-STAR.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Biomarkers; Creatinine; Drug Resistance; Female; Follow-Up Studies; Furosemide; Heart Failure; Humans; Male; Prospective Studies; Renal Insufficiency; Sodium; Sodium Potassium Chloride Symporter Inhibitors; Time Factors; Tolvaptan; Treatment Outcome | 2019 |
Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiovascular Agents; Disease Progression; Double-Blind Method; Female; Heart Failure; Hematocrit; Hospitalization; Humans; Kidney Function Tests; Male; Middle Aged; Natriuretic Peptides; Outcome Assessment, Health Care; Prognosis; Renal Insufficiency; Stroke Volume; Survival Analysis; Tolvaptan | 2013 |
Clinical effectiveness of tolvaptan in patients with acute decompensated heart failure and renal failure: design and rationale of the AQUAMARINE study.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Drug Therapy, Combination; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Japan; Natriuretic Peptide, Brain; Prospective Studies; Renal Insufficiency; Research Design; Tolvaptan | 2014 |
Population-based meta-analysis of hydrochlorothiazide pharmacokinetics.
Topics: Adult; Antihypertensive Agents; Benzazepines; Diuretics; Heart Failure; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Models, Biological; Renal Insufficiency; Tolvaptan; Young Adult | 2013 |
Early administration of tolvaptan preserves renal function in elderly patients with acute decompensated heart failure.
Topics: Acute Disease; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Hospitalization; Humans; Male; Renal Insufficiency; Tolvaptan | 2016 |
Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction.
Topics: Acute Disease; Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuresis; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Heart Failure; Humans; Male; Prospective Studies; Renal Insufficiency; Tolvaptan; Treatment Outcome | 2016 |
Prognostic impact of early treatment with tolvaptan in patients with acute heart failure and renal dysfunction.
Topics: Acute Disease; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Comorbidity; Early Medical Intervention; Female; Glomerular Filtration Rate; Heart Failure; Hospitalization; Humans; Kidney Function Tests; Male; Middle Aged; Prognosis; Renal Insufficiency; Tolvaptan; Treatment Outcome | 2016 |
Efficacy of oral tolvaptan in acute heart failure patients with hypotension and renal impairment.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiovascular Agents; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Hypotension; Male; Middle Aged; Renal Insufficiency; Sodium; Tolvaptan; Treatment Outcome | 2012 |
7 other study(ies) available for tolvaptan and Kidney Failure
| Article | Year |
|---|---|
Prostaglandin E2, Osmoregulation, and Disease Progression in Autosomal Dominant Polycystic Kidney Disease.
Topics: Antidiuretic Hormone Receptor Antagonists; Dinoprostone; Disease Progression; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Kidney; Male; Osmoregulation; Polycystic Kidney, Autosomal Dominant; Prospective Studies; Renal Insufficiency; Tolvaptan | 2023 |
Protective effect of tolvaptan against cyclophosphamide-induced nephrotoxicity in rat models.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Antineoplastic Agents; Apoptosis; Cyclophosphamide; Cytokines; Heart Failure; Hyponatremia; Injections, Intraperitoneal; Kidney Function Tests; Lipid Peroxidation; Liver Cirrhosis; Male; Models, Animal; Oxidative Stress; Protective Agents; Rats; Receptors, Vasopressin; Renal Insufficiency; Tolvaptan | 2020 |
Tolvaptan alleviates excessive fluid retention of nephrotic diabetic renal failure unresponsive to furosemide.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diabetic Nephropathies; Drug Resistance; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Nephrotic Syndrome; Renal Insufficiency; Severity of Illness Index; Sodium Potassium Chloride Symporter Inhibitors; Time Factors; Tolvaptan; Treatment Outcome; Water-Electrolyte Balance | 2018 |
Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan trial).
Topics: Age Factors; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Black or African American; Blood Pressure; Female; Glomerular Filtration Rate; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Natriuretic Peptides; Prognosis; Proportional Hazards Models; Renal Insufficiency; Risk Factors; Sex Factors; Stroke Volume; Systole; Tolvaptan; Treatment Outcome; Uric Acid; Ventricular Dysfunction, Left; White People | 2014 |
Tolvaptan in a pediatric patient with diuretic-resistant heart and kidney failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Child; Diuretics; Drug Resistance; Heart Failure; Humans; Male; Renal Insufficiency; Tolvaptan | 2015 |
Early introduction of tolvaptan after cardiac surgery: a renal sparing strategy in the light of the renal resistive index measured by ultrasound.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiovascular Surgical Procedures; Echocardiography, Doppler; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Postoperative Complications; Renal Insufficiency; Retrospective Studies; Tolvaptan; Treatment Outcome | 2015 |
Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Comparative Effectiveness Research; Creatinine; Diuresis; Diuretics; Female; Furosemide; Heart Failure; Humans; Hypernatremia; Kidney Function Tests; Male; Multivariate Analysis; Natriuretic Peptide, Brain; Prospective Studies; Renal Insufficiency; Time Factors; Tolvaptan; Urination | 2013 |